跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Authorized
STANDARD
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
aa pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3c50818de959b09e
Company
aa pharma inc
Type
Standard
Approval Details
Approval Id
3c50818de959b09e
Drug Approval Canada Name
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Product Name
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Status
Marketed
Status Date
2022-10-04
Original Market Date
2018-08-03
Din
02470780
Drug Class
Human
Dosage Form
Capsule , Kit , Tablet , Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.12.08
Atc Original
A02BD07 LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
Atc Name
a 02 bd 07
Aig Number
0334201001
Company Name
aa pharma inc
Company Address
UNIT 1, 1165 Creditstone Road, Vaughan, Ontario, Canada, L4K 4N7
Active Ingredients
AMOXICILLIN
500 MG / CAP
CLARITHROMYCIN
500 MG / TAB
LANSOPRAZOLE
30 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3c50818de959b09e
Type
Standard
Back to Health Canada Approvals